OpenEvidence and Penn Medicine Partner to Extend AI Clinical Decision Support to Botswana
OpenEvidence and Penn Medicine have partnered to integrate AI-powered clinical decision support tools into Penn's health system. The initiative also aims to expand these resources to Botswana through the long-standing Botswana-UPenn Partnership.
Why it matters
This partnership represents a significant step in using AI to bridge the gap in medical expertise between high-resource and low-resource healthcare settings.
OpenEvidence and Penn Medicine announced a global partnership on September 15, 2026 to deploy OpenEvidence’s AI-powered clinical decision-making platform across Penn Medicine’s more than 10,000 clinicians, with plans to extend the tools to low- and middle-income countries through the 25-year-old Botswana-UPenn Partnership (BUP). Travis Zack, MD, PhD , Chief Medical Officer of OpenEvidence, framed the collaboration around access: “OpenEvidence was founded on the belief that the best available medical evidence should reach every clinician, not only those working inside the world’s best resourced hospitals.”
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in